Abstract
Establishment of a relation between any clinical variable of MS such as disease activity or duration, and aberrations of CSF immunoglobulins is hampered by several difficulties. Clinical variables are often difficult to define. Thus, an exacerbation may be simulated by changes of body temperature, or plaques may develop in areas of white matter without presenting any clinical signs and symptoms. One or two strategically located plaques may induce profound disability while, in other patients, extensive dissemination of plaques may be accompanied by no or only slight disability. Furthermore, various “treatment” protocols nowadays used in many centres include drugs which modulate the immune response and have long-lasting effects on e.g. Ig levels in CSF. These may be some of the reasons why, in the vast literature on MS, few studies deal with relation between clinical variables and Ig aberrations in CSF even though these aberrations after all might have importance for the pathogenesis of the disease. Thus, modern laboratory tests such as nuclear magnetic resonance studies or determinations of myelin basic protein levels in CSF in MS patients in order to establish disease activity more appropriately, have hitherto not been related to Ig concentrations in CSF.
Keywords
- Multiple Sclerosis
- Oligoclonal Band
- Nuclear Magnetic Reso
- Multiple Sclerosis Research
- Myelin Basic Protein Level
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Forsberg, P., Henriksson, A., Link, H. and Ohman, S., 1984. Reference for CSF-IgM, CSF-IgM/S-IgM ratio and IgM index, and its application to patients with multiple sclerosis and aseptic meningoencephalitis. Scand. J. Clin. Lab. Invest., 44: 7–12.
Henriksson, A., Kam-Hansen, S. and Andersson, R., 1981. Immunoglobulin- producing cells in CSF and blood from patients with multiple sclerosis and other neurological diseases enumerated by Protein-A plaque assay. J. Neuroimmunol., 1: 299–309.
Henriksson, A., Kam-Hansen, S. and Link, H., 1985. IgM, IgA and IgG pro-duction cells in cerebrospinal fluid and peripheral blood in multiple sclerosis. Ann. Neurol., submitted.
Link, H. and Müller, R., 1971. Immunoglobulins in multiple sclerosis and infections of the nervous system. Arch. Neurol. ( Chic. ), 25: 326–344.
Mingioli, E.S., Strober, W., Tourtellotte, W.W., Whitaker, J.N. and McFarlin, D.E., 1978. Quantitation of IgG, IgA and IgM in the CSF by radioimmunoassay. Neurology, 28: 991–995.
Olsson, J.E. and Link, H., 1973. Immunoglobulin abnormalities in multiple sclerosis — Relation to clinical parameters — Exacerbations and remissions. Arch. Neurol. ( Chic. ), 28: 392–399.
Olsson, J.E., Link, H. and Müller, R., 1976, Immunoglobulin abnormalities in multiple sclerosis. Relation to clinical parameters: Disability, duration and age of onset. J. Neurol. Sci., 27: 233–245.
Olsson, T., Kostulas, V. and Link, H., 1984. Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. Clin. Chem., 30: 1246–1249.
Sindic, C.J., Cambiaso, C.L., Depre, A., Laterre, E.C. and Masson, P.L., 1982. The concentration of IgM in the cerebrospinal fluid of neurological patients. J. Neurol. Sci., 55: 339–350.
Stendahl-Brodin, L. and Link, H., 1980. Relation between benign course of multiple sclerosis and low-grade humoral inmune response in cerebrospinal fluid. J. Neurol. Neurosurg. Psychiat., 43: 102–105.
Stendahl-Brodin, L. and Link, H., 1983. Optic neuritis: Oligoclonal bands increase the risk of multiple sclerosis. Acta Neurol. Scand., 67: 301–304.
Tourtellotte, W.W. and Ma, B.I., 1978. Multiple sclerosis: The blood- brain barrier and the measurements of de novo central nervous system IgG synthesis. Neurology (part 2 ), 28: 76–83.
Walsh, M.J. and Tourtellotte, W.W., 1983. The cerebrospinal fluid in multiple sclerosis. In: J.F. Hallpike, C.W.M. Adams, W.W. Tourtellotte eds., Multiple sclerosis. Williams and Wilkins, Baltimore, pp 275–358.
Williams, A.C., Mingioli, E.S., McFarland, H.F., Tourtellotte, W.W. and McFarlin, D.E., 1978. Increased CSF IgM in multiple sclerosis. Neurology, 28: 996–998.
Yahr, M.D., Goldensohn, S.S. and Kabat, E.A., 1954. Further studies on the gamma globulin content of cerebrospinal fluid in multiple sclerosis and other neurological diseases. Ann. N.Y. Acad. Sci., 58: 613–624.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 ECSC, EEC, EAEC, Brussels and Luxembourg
About this chapter
Cite this chapter
Link, H. (1986). CSF Immunoglobulins and Clinical Course. In: Hommes, O.R. (eds) Multiple Sclerosis Research in Europe. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-4143-4_32
Download citation
DOI: https://doi.org/10.1007/978-94-009-4143-4_32
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-8338-6
Online ISBN: 978-94-009-4143-4
eBook Packages: Springer Book Archive